What is the Difference Between MDR and XDR-TB?
🆚 Go to Comparative Table 🆚The main difference between multidrug-resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-TB) lies in the level of resistance to anti-TB drugs. Here are the key differences:
- Multidrug-Resistant TB (MDR-TB): MDR-TB is caused by TB bacteria that are resistant to at least isoniazid and rifampin, the two most potent TB drugs. This means that the standard first-line treatment for TB is not effective against MDR-TB.
- Extensively Drug-Resistant TB (XDR-TB): XDR-TB is a rare type of MDR-TB that is resistant to isoniazid, rifampin, a fluoroquinolone, and at least one of three injectable second-line drugs (amikacin, kanamycin, or capreomycin). In some cases, XDR-TB can also be resistant to bedaquiline or linezolid. This means that XDR-TB is resistant to the most potent TB drugs, leaving patients with treatment options that are much less effective.
Both MDR-TB and XDR-TB are more difficult to treat compared to drug-susceptible TB. They require longer treatment durations and come with potentially life-threatening side effects. XDR-TB is especially concerning, as it is more resistant to a larger range of drugs, making treatment even more challenging.
Comparative Table: MDR vs XDR-TB
Here is a table comparing the differences between MDR-TB (Multidrug-Resistant Tuberculosis) and XDR-TB (Extensively Drug-Resistant Tuberculosis):
Feature | MDR-TB | XDR-TB |
---|---|---|
Definition | Resistant to at least isoniazid and rifampicin | Resistant to at least isoniazid, rifampicin, and any fluoroquinolone, and at least one of the injectable drugs (i.e., amikacin, kanamycin, or capreomycin) |
Treatment | Longer treatment duration than ordinary TB, but can still be treated with second-line drugs | Resistant to both first- and second-line drugs, making treatment more difficult and prolonged |
Cure Rate | Lower than ordinary TB, but still curable with proper treatment | Practically incurable by standard first-line treatment, but can still be treated with second-line drugs |
Diagnosis | Detected through drug-susceptibility testing (DST) | Detected through drug-susceptibility testing (DST), with newer molecular methods providing results within hours |
Prevalence | Higher than ordinary TB, but lower than XDR-TB | Lower than MDR-TB, but still a significant concern |
Both MDR-TB and XDR-TB are due to the misuse and mismanagement of TB drugs, causing the bacteria to become resistant to the medications. Early and accurate diagnosis is crucial for effective treatment of both MDR-TB and XDR-TB.
- Mycobacterium Tuberculosis vs Mycobacterium Leprae
- Typhoid vs Tuberculosis
- Pertussis vs Tuberculosis
- Primary vs Secondary Tuberculosis
- Mycobacterium Tuberculosis vs Nontuberculous Mycobacteria
- Sarcoidosis vs Tuberculosis
- Tuberculosis vs Paratuberculosis
- Multidrug Resistance vs Cross Resistance
- MDI vs TDI
- Mycobacterium Tuberculosis vs Mycobacterium Bovis
- TB Meningitis vs Bacterial Meningitis
- Tuberculosis vs Pneumonia
- Lung Cancer vs Tuberculosis
- EMR vs EHR
- Buruli Ulcer vs Leprosy
- BMD vs DMD
- TDP vs TDT
- MDD vs Dysthymia
- MBBS vs MD